openPR Logo
Press release

Rheumatic Heart Disease Market Analysis, Trends, Growth, Size, Forecast 2023

06-27-2020 06:11 PM CET | Health & Medicine

Press release from: Orion Market Research

Rheumatic Heart Disease Market

Rheumatic Heart Disease Market

Rheumatic heart disease is an inflammatory disease that start with a normal strep throat, fever and multiple joint pains. Further, non-treating of these symptoms involve heart and damages the heart valves and leads to rheumatic heart disease(RHD). Streptococcus pyogenes are the main bacterium which causes rheumatic fever. These infectious agents came in contact with human body via various toxic materials from environment such as water, food, air, toxic gases, smoke, and pollution.

Request a Free Sample of our Report on Rheumatic Heart Disease Market: https://www.omrglobal.com/request-sample/rhd-rheumatic-heart-disease-market

Increasing environmental pollution resulting in higher prevalence of viral and fungal infection is one of the major factor motivating the growth of this market. In addition, increasing healthcare expenditure by government to tackle rising prevalence of cardiovascular disease is another motivating factor for the market. However, its high medical treatment and limited healthcare facilities in emerging economies may restrict the growth of this market. Furthermore, Continuous improvement by leading market players in Rheumatic heart disease drug and development in biotechnology has brought new opportunity to Rheumatic heart disease market.

Geographically Rheumatic heart disease market is divided into north America, Europe, Asia pacific and rest of the world. The growing number of collaboration and partnership by major pharmaceutical companies, to provide better healthcare facilities in Europe is the market driver in the European region. The global players in the rheumatic heart disease market includes Abbott laboratories, Johnson & Johnson, F. Hoffmann-La Roche Ltd, Novartis AG, Pfizer. The strategy adopted in these companies are continuous investments in R&D which made them progress over the past several years in various drug discovery for Rheumatic heart diseases. Continuous improvement on Rheumatic heart disease drug enable market player to offer high-value product and services at lower cost.

A Full Report of Rheumatic Heart Disease Market is Available at https://www.omrglobal.com/industry-reports/rhd-rheumatic-heart-disease-market

Global Rheumatic Heart Disease Market Segmentation

By Treatment

• Anitibiotics Medication
• Anti-Convulsant Medication
• Anti-Inflamatory Treatment
• Surgical Treatment

By End-User

• Hospital
• Diagnostic Centre
• Research Centre
• Others

By Type

• Valve
o Aortic Valve
o Mitral Valve
o Myocarditis
o Pericarditis

By Diagnostic Test

• Electrocardiogram
• Echocardiogram
• Blood Test
• Imaging

Company Profiles

• Abbott Laboratories
• Bayer Ag
• Biotronik
• Boston Scientific Corporation
• Bristol-Myers Squibb Company
• C. R. Bard, Inc.
• Cardinal Health
• Cook Medical
• F. Hoffmann-La Roche Ltd
• Ge Healthcare
• Intervalve Medical Inc.
• Novartis Ag
• On-X Life Technologies Inc.

For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/rhd-rheumatic-heart-disease-market

For More Information, Visit https://www.omrglobal.com/

Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 780-304-0404

About us:
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Rheumatic Heart Disease Market Analysis, Trends, Growth, Size, Forecast 2023 here

News-ID: 2081095 • Views:

More Releases from Orion Market Research

Digital Innovation in Insurance Market Size Analysis, Competitive Insights, Leading Players and Growth Opportunities by 2033
Digital Innovation in Insurance Market Size Analysis, Competitive Insights, Lead …
The Global Digital Innovation in Insurance Market is projected to reach around USD 250 billion by 2033, growing at a compound annual growth rate (CAGR) of approximately 9.5% from 2024 to 2033. Digital Innovation in Insurance Market Overview The Digital Innovation in Insurance Market encompasses the integration of advanced technologies such as Artificial Intelligence (AI), Blockchain, the Internet of Things (IoT), and Big Data analytics into the insurance sector. These innovations are
Cigarette Rolling Paper Market - Industry Trends and Forecast to 2033
Cigarette Rolling Paper Market - Industry Trends and Forecast to 2033
The Global Cigarette Rolling Paper Market was valued at approximately USD 2.9 billion in 2024 and is projected to reach around USD 41.8 billion by 2033, reflecting a compound annual growth rate (CAGR) of approximately 34.5% from 2024 to 2033. Cigarette Rolling Paper Market Overview The Global Cigarette Rolling Paper Market has experienced significant growth, driven by increasing consumer preference for hand-rolled cigarettes, particularly among younger and budget-conscious smokers. These papers
Back Glue Market: Emerging Trends and Growth Forecast to 2033
Back Glue Market: Emerging Trends and Growth Forecast to 2033
The Global Back Glue Market is projected to reach around USD 3.0 billion by 2033, growing at a compound annual growth rate (CAGR) of approximately 7.1% from 2024 to 2033. Back Glue Market Overview The Global Back Glue Market encompasses adhesives designed for various applications, including bookbinding, phone back panels, and other industrial uses. Advancements in technology have led to the development of high-performance back glue adhesives, which are anticipated to drive
Autopilot Systems Market Overview: Growth, Share, Value, Size, and Scope
Autopilot Systems Market Overview: Growth, Share, Value, Size, and Scope
The Global Autopilot Systems Market was valued at approximately USD 5.8 billion in 2023 and is projected to reach around USD 10.6 billion by 2033, reflecting a compound annual growth rate (CAGR) of approximately 6.4% from 2024 to 2033. Autopilot Systems Market Overview The Global Autopilot Systems Market encompasses advanced flight control systems designed to automate the navigation and operation of aircraft, reducing the need for manual input by pilots. These

All 5 Releases


More Releases for Rheumatic

Rheumatic Diseases Market Size, Growth, Research Report & Trends 2023-2033
Rheumatic Diseases Market Report Overview:   Report Attribute Details Base Year 2022 Forecast Years
Rheumatic Fever Treatment Market - Comprehensive Solutions, Lasting Impact: Rheu …
Newark, New Castle, USA: The "Rheumatic Fever Treatment Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors Rheumatic Fever Treatment Market: https://www.growthplusreports.com/report/rheumatic-fever-treatment-market/8798 This latest report researches the industry structure,
Rheumatic Heart Disease Management Market Size | Pfizer Inc., Sanofi S.A.
[100 pages] Report "Rheumatic Heart Disease Management Market" detailed analysis of a business is mainly segmented by Application, by Type, Region (North America, Europe, Asia-Pacific, South America, and Middle East & Africa), manufacture and Forecast to 2031. "Final Report will add the analysis of the impact of COVID-19 on this industry." Global "Rheumatic Heart Disease Management Market" report analyses the best market prospects and lists the characteristics that are and will continue
Rheumatic Fever Treatment Market 2021 – 2030
Acumen Research and Consulting has recently published a research report on the Rheumatic Fever Treatment Market for the forecast period of 2019-2026, wherein, the global market has been analyzed and assessed in an extremely comprehensive manner. The research report on the Rheumatic Fever Treatment Market offers an extensive analysis of how the postoperative pain therapeutics landscape would evolve through 2026. The research study on the Rheumatic Fever Treatment Market analyzes key
Significant Growth Opportunities for Players in the Rheumatic Disorders Drugs Ma …
The rheumatic disorder therapy area is multi-disciplinary in nature and encompasses conditions that affect joints, connective tissue, ligaments, tendons, cartilage, bone and muscle and which are characterized by chronic pain and a consequent reduction in function and motion. The majority of rheumatic disorders are treated using largely genericized pain management drugs, and there are no cures for any of the key indications, leaving a large unmet need for better disease-modifying
Rheumatic Heart Disease Market Trends, Size, Competitive Analysis and Forecast 2 …
Rheumatic heart disease is an inflammatory disease that start with a normal strep throat, fever and multiple joint pains. Further, non-treating of these symptoms involve heart and damages the heart valves and leads to rheumatic heart disease(RHD). Streptococcus pyogenes are the main bacterium which causes rheumatic fever. These infectious agents came in contact with human body via various toxic materials from environment such as water, food, air, toxic gases, smoke,